6.
Gupta S, Eavey R, Wang M, Curhan S, Curhan G
. Type 2 diabetes and the risk of incident hearing loss. Diabetologia. 2018; 62(2):281-285.
PMC: 6494103.
DOI: 10.1007/s00125-018-4766-0.
View
7.
Chen Y, Xin Y, Cheng Y, Liu X
. Mitochondria-Endoplasmic Reticulum Contacts: The Promising Regulators in Diabetic Cardiomyopathy. Oxid Med Cell Longev. 2022; 2022:2531458.
PMC: 9017569.
DOI: 10.1155/2022/2531458.
View
8.
Chapman F, Maguire J, Newby D, Davenport A, Dhaun N
. Targeting the apelin system for the treatment of cardiovascular diseases. Cardiovasc Res. 2023; 119(17):2683-2696.
PMC: 10757586.
DOI: 10.1093/cvr/cvad171.
View
9.
Lyu A, Kim T, Shin S, Kim E, Yu Y, Gajbhiye A
. Hearing Impairment in a Mouse Model of Diabetes Is Associated with Mitochondrial Dysfunction, Synaptopathy, and Activation of the Intrinsic Apoptosis Pathway. Int J Mol Sci. 2021; 22(16).
PMC: 8395823.
DOI: 10.3390/ijms22168807.
View
10.
Li C, Cheng H, Adhikari B, Wang S, Yang N, Liu W
. The Role of Apelin-APJ System in Diabetes and Obesity. Front Endocrinol (Lausanne). 2022; 13:820002.
PMC: 8959308.
DOI: 10.3389/fendo.2022.820002.
View
11.
Zheng X, Huang Y, Li H
. Regulatory role of Apelin-13-mediated PI3K/AKT signaling pathway in the glucose and lipid metabolism of mouse with gestational diabetes mellitus. Immunobiology. 2021; 226(5):152135.
DOI: 10.1016/j.imbio.2021.152135.
View
12.
Lee S, Lee I, Jeon J
. Vascular Calcification-New Insights Into Its Mechanism. Int J Mol Sci. 2020; 21(8).
PMC: 7216228.
DOI: 10.3390/ijms21082685.
View
13.
Yao L, Liang X, Qiao Y, Chen B, Wang P, Liu Z
. Mitochondrial dysfunction in diabetic tubulopathy. Metabolism. 2022; 131:155195.
DOI: 10.1016/j.metabol.2022.155195.
View
14.
Niknazar S, Abbaszadeh H, Peyvandi H, Rezaei O, Forooghirad H, Khoshsirat S
. Protective effect of [Pyr1]-apelin-13 on oxidative stress-induced apoptosis in hair cell-like cells derived from bone marrow mesenchymal stem cells. Eur J Pharmacol. 2019; 853:25-32.
DOI: 10.1016/j.ejphar.2019.03.012.
View
15.
Horikawa C, Kodama S, Tanaka S, Fujihara K, Hirasawa R, Yachi Y
. Diabetes and risk of hearing impairment in adults: a meta-analysis. J Clin Endocrinol Metab. 2012; 98(1):51-8.
DOI: 10.1210/jc.2012-2119.
View
16.
Knapp M, Tu X, Wu R
. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacol Sin. 2018; 40(1):1-8.
PMC: 6318313.
DOI: 10.1038/s41401-018-0042-6.
View
17.
Zhu J, Dou S, Jiang Y, Chen J, Wang C, Cheng B
. Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy. Brain Res. 2019; 1715:203-212.
DOI: 10.1016/j.brainres.2019.03.027.
View
18.
Kim S, Kim S, Hwang A, Choi H, Lee J, Woo C
. Apelin-13 Inhibits Methylglyoxal-Induced Unfolded Protein Responses and Endothelial Dysfunction via Regulating AMPK Pathway. Int J Mol Sci. 2020; 21(11).
PMC: 7313041.
DOI: 10.3390/ijms21114069.
View
19.
Rizwan H, Pal S, Sabnam S, Pal A
. High glucose augments ROS generation regulates mitochondrial dysfunction and apoptosis via stress signalling cascades in keratinocytes. Life Sci. 2019; 241:117148.
DOI: 10.1016/j.lfs.2019.117148.
View
20.
Read C, Nyimanu D, Williams T, Huggins D, Sulentic P, Macrae R
. International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand. Pharmacol Rev. 2019; 71(4):467-502.
PMC: 6731456.
DOI: 10.1124/pr.119.017533.
View